A rating of 62 puts Lyell Immunopharma Inc (LYEL) near the middle of the Biotechnology industry according to InvestorsObserver. Lyell Immunopharma Inc's score of 62 means it scores higher than 62% of stocks in the industry. Lyell Immunopharma Inc also received an overall rating of 57, putting it above 57% of all stocks. Biotechnology is ranked 20 out of the 148 industries.
LYEL has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on LYEL!